Trial Profile
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN 131 Transdermal System (TDS) as Compared to Placebo TDS in Adult Patients With a Chalazion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2017
Price :
$35
*
At a glance
- Drugs SUN 131 (Primary)
- Indications Chalazion
- Focus Therapeutic Use
- Sponsors Senju Pharmaceutical
- 11 Feb 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 09 Dec 2015 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016, according to ClinicalTrials.gov record.
- 09 Dec 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2016, according to ClinicalTrials.gov record.